# FDA recall D-0150-2017

> **Pfizer Inc.** · Class II · drug recall initiated 2016-11-07.

## Product

LEVOXYL(R) (levothyroxine sodium tablets, USP), 200 mcg, 100 count bottles, Rx only, Manufactured and Distributed by:  King Pharmaceuticals, Inc., Bristol, TN 37620, NDC 60793-860-01

## Reason for recall

Superpotent

## Distribution

Nationwide

## Key facts

- **Recall number:** D-0150-2017
- **Recalling firm:** Pfizer Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2016-11-07
- **Report date:** 2016-11-30
- **Termination date:** 2020-05-01

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** New York, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0150-2017

## Citation

> AI Analytics. FDA recall D-0150-2017. Retrieved 2026-05-26 from https://api.ai-analytics.org/recall/D-0150-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*